摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2R,3R,4S,5S,6S)-2-(butoxymethyl)-6-methoxy-3,5-diphosphonooxyoxan-4-yl] dihydrogen phosphate

中文名称
——
中文别名
——
英文名称
[(2R,3R,4S,5S,6S)-2-(butoxymethyl)-6-methoxy-3,5-diphosphonooxyoxan-4-yl] dihydrogen phosphate
英文别名
——
[(2R,3R,4S,5S,6S)-2-(butoxymethyl)-6-methoxy-3,5-diphosphonooxyoxan-4-yl] dihydrogen phosphate化学式
CAS
——
化学式
C11H25O15P3
mdl
——
分子量
490.23
InChiKey
PPDCEIYJUPAMIB-UVOCVTCTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -4.1
  • 重原子数:
    29
  • 可旋转键数:
    12
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    228
  • 氢给体数:
    6
  • 氢受体数:
    15

文献信息

  • The use of growth factor modulation compounds substituted with three vicinal phosphorus containing radical in the manufacture of a medicament for tissue repair
    申请人:PERSTORP AB
    公开号:EP1216705A2
    公开(公告)日:2002-06-26
    The invention relates to the use of a compound containing a high density, negatively charged domain of vicinally oriented radicals for the preparing of a medicament providing a growth factor modulating activity in mammals including man.
    本发明涉及一种含有高密度、带负电荷的邻接基域的化合物,用于制备对哺乳动物(包括人类)具有生长因子调节活性的药物。
  • Use of growth factor modulating compounds
    申请人:——
    公开号:US20020065253A1
    公开(公告)日:2002-05-30
    The present invention relates to a method of treating angiogenesis in tumor conditions in a mammal suffering therefrom which comprises administering to a mammal in need thereof an effective amount of a cyclic compound selected from the group consisting of cyclopentane, cyclohexane, cycloheptane, monosaccharide, disaccharide, trisaccharide, tetrasaccharide, piperidine, tetrahydrothiopyran, 5-oxotetrahydrothiopyran, 5,5-dioxotetrahydrothiopyran, tetrahydroselenopyran, tetrahydrofuran, pyrrolidine, tetrahydrothiophene, 5-oxotetrahydrothiophene, 5,5-dioxotetrahydrothiophene, tetrahydroselenophene, benzene, cumene, mesitylene, naphthalene and phenanthrene, in which said cyclic compound is substituted by at least three vicinal phosphorus containing radicals of the formula: 1 The present application is also directed to the use of these compounds for treating inflammatory conditions, tissue repair conditions and/or infectious conditions in a mammal.
    本发明涉及一种治疗患有肿瘤的哺乳动物体内血管生成的方法,该方法包括向有需要的哺乳动物施用有效量的环状化合物,该环状化合物选自由环戊烷、环己烷、环庚烷、单糖、二糖、三糖、四糖、哌啶、四氢噻喃、5-氧代四氢噻喃、5,5-二氧代四氢噻喃、四氢硒喃、四氢呋喃、吡咯烷、四氢苯并呋喃、5-氧代四氢噻喃、四氢噻喃、5-氧代四氢噻喃、5,5-二氧代四氢噻喃、四氢呋喃、吡咯烷、四氢噻吩、5-氧代四氢噻吩、5,5-二氧代四氢噻吩、四氢硒吩、苯、积烯、间苯二酚、萘和菲,其中所述环状化合物至少被三个邻接的含磷基取代,其式如下 1 本申请还涉及使用这些化合物治疗哺乳动物的炎症、组织修复和/或感染性疾病。
  • Use of a compound with a negatively charged domain of radicals for the treatment of restenosis
    申请人:——
    公开号:US20040235799A1
    公开(公告)日:2004-11-25
    There is disclosed the use of a compound containing a high density negatively charged domain of vicinally oriented radicals for the preparing of a medicament for preventing, alleviating or combating restenosis in mammals including man.
    本文公开了一种含有高密度带负电荷的沧海基域的化合物,用于制备预防、缓解或抗击哺乳动物(包括人类)血管再狭窄的药物。
  • METHOD OF TREATING INFLAMMATORY, TISSUE REPAIR AND INFECTIOUS CONDITIONS
    申请人:Siren Matti
    公开号:US20050227946A1
    公开(公告)日:2005-10-13
    The present invention relates to a method of treating inflammatory, tissue repair and infectious conditions in a mammal suffering therefrom which comprises administering to a mammal in need thereof an effective amount of a cyclic compound selected from the group consisting of cyclopentane, cyclohexane, cycloheptane, monosaccharide. disaccharide, trisaccharide, tetrasaccharide, piperidine, tetrahydrothiopyran, 5-oxotetrahydrothiopyran, 5,5-dioxotetrahydrothiopyran, tetrahydroselenopyran, tetrahydrofuran, pyrrolidine, tetrahydrothiophene, 5-oxotetrahydrothiophene, 5,5-dioxotetrahydrothiophene, tetrahydroselenophene, benzene, cumene, mesitylene, naphthalene and phenanthrene, in which said cyclic compound is substituted by at least three vicinal phosphorus containing radicals of the formula:
    二糖、三糖、四糖、哌啶、四氢噻喃、5-氧代四氢噻喃、5,5-二氧代四氢噻喃、四氢硒喃、四氢呋喃、吡咯烷、四氢噻吩、5-氧代四氢噻吩、5,5-二氧代四氢噻吩、四氢硒吩、苯、积烯、间苯二酚、萘和菲,其中所述环状化合物至少被三个如下式的含磷基取代:
  • DERIVATIVES OF CARBOHYDRATES AND COMPOSITIONS CONTAINING THEM
    申请人:PERSTORP AB
    公开号:EP0793668A1
    公开(公告)日:1997-09-10
查看更多